Completed
A Single Ascending Dose Study of Daclatasvir (BMS-790052) in Hepatitis C Virus Infected Subjects
NCT00546715
- Conditions
- Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
- Locations
-
- Advanced Clinical Research Institute Anaheim, California, United States
- Orlando Clinical Research Center Orlando, Florida, United States
- Parexel International Corporation Baltimore, Maryland, United States
- Mayo Clinic Rochester, Minnesota, United States